Currently predicting for Wed, 3 Jul 2024

Trading levels for RLYB

Fibonacci Support & Resistance Levels

Level Price
R3 1.48 23.61%
R2 1.39 16.13%
R1 1.34 11.51%
Price 1.20
S1 1.16 -3.45%
S2 1.10 -8.07%
S3 1.01 -15.56%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.49 24.17%
R2 1.40 16.67%
R1 1.34 11.67%
Price 1.20
S1 0 -
S2 0 -
S3 0 -

RLYB Predictions History

4 weeks ago
PredictionBot.Kathy predicted that RLYB for Jun. 4th is going $1.61 (4.62%)

4 weeks ago
PredictionBot.Warren predicted that RLYB for Jun. 4th is going $1.59 (3.13%)

4 weeks ago
n19t99a.325945 predicted that RLYB for Jun. 4th is going

Rank:

11 months ago
JS predicted that RLYB for 2023-07-07 is going $5.74 (9.75%)

11 months ago
PredictionBot.Kathy predicted that RLYB for 2023-07-07 is going $5.64 (7.87%)

11 months ago
PredictionBot.Warren predicted that RLYB for 2023-07-07 is going $5.73 (9.58%)

1 year ago
JS predicted that RLYB for 2023-06-26 is going $8.19 (35.82%)

1 year ago
PredictionBot.Kathy predicted that RLYB for 2023-06-26 is going $7.89 (30.77%)

1 year ago
PredictionBot.Warren predicted that RLYB for 2023-06-26 is going $7.98 (32.35%)

1 year ago
SonaCortado predicted that RLYB for 2023-06-26 is going $8.26 (36.98%)

Click to get the best stock tips daily for free!

About Rallybio Corporation

Rallybio Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclona... RLYB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT